EMA Green Lights Accelerated Program for RNAi Therapeutic

News   Mar 02, 2017 | Original story Alnylam

 
EMA Green Lights Accelerated Program for RNAi Therapeutic

Credit: EMA

 
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS

News

Researchers have used CRISPR to correct the molecular mistakes that lead to microsatellite repeat expansion diseases, which include myotonic dystrophy types 1 and 2, the most common form of hereditary ALS, and Huntington's disease.

READ MORE

Circular RNA Linked to Brain Function

News

When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE